{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:43:47Z","timestamp":1790696627284,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Higher Education Malaysia Fundamental Research Grant Scheme","award":["FRGS\/1\/2023\/SKK15\/UPM\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2023\/SKK15\/UPM\/02\/3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02914-4","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:22:36Z","timestamp":1761564156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Curcumin-like diarylpentanoid analogues exhibit antiviral and anti-inflammatory activities in influenza A virus-infected A549 lung epithelial cells by inhibiting multiple retinoic acid-inducible gene I (RIG-I)-mediated pathways"],"prefix":"10.1186","volume":"22","author":[{"given":"Kong Yen","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yee","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faridah","family":"Abas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Wei","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanis Hazeera","family":"Harith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tatt","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Roslan","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau Ling","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2914_CR1","doi-asserted-by":"publisher","first-page":"A6","DOI":"10.1016\/J.VACCINE.2020.09.048","volume":"39","author":"AE Macias","year":"2021","unstructured":"Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39:A6. https:\/\/doi.org\/10.1016\/J.VACCINE.2020.09.048.","journal-title":"Vaccine"},{"key":"2914_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/S12276-021-00603-0","volume":"53","author":"WN Harrington","year":"2021","unstructured":"Harrington WN, Kackos CM, Webby RJ. The evolution and future of influenza pandemic preparedness. Exp Mol Med. 2021;53:737\u201349. https:\/\/doi.org\/10.1038\/S12276-021-00603-0.","journal-title":"Exp Mol Med"},{"key":"2914_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IDR.S105473","volume":"10","author":"M Hussain","year":"2017","unstructured":"Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M. Drug resistance in influenza A virus: the epidemiology and management. Infect Drug Resist. 2017;10:121. https:\/\/doi.org\/10.2147\/IDR.S105473.","journal-title":"Infect Drug Resist"},{"key":"2914_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","volume":"13","author":"Q Liu","year":"2015","unstructured":"Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2015;13:3\u201310. https:\/\/doi.org\/10.1038\/cmi.2015.74.","journal-title":"Cell Mol Immunol"},{"key":"2914_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/V13071362","author":"Y Gu","year":"2021","unstructured":"Gu Y, Zuo X, Zhang S, Ouyang Z, Jiang S, Wang F, et al. The mechanism behind influenza virus cytokine storm. Viruses. 2021. https:\/\/doi.org\/10.3390\/V13071362.","journal-title":"Viruses"},{"issue":"S9","key":"2914_CR6","doi-asserted-by":"publisher","first-page":"S2248","DOI":"10.21037\/JTD.2018.03.169","volume":"10","author":"Z Li","year":"2018","unstructured":"Li Z, Li L, Zhao S, Li J, Zhou H, Zhang Y, et al. Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies. J Thorac Dis. 2018;10(S9):S2248. https:\/\/doi.org\/10.21037\/JTD.2018.03.169.","journal-title":"J Thorac Dis"},{"key":"2914_CR7","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.4049\/JIMMUNOL.178.6.3368","volume":"178","author":"R Le Goffic","year":"2007","unstructured":"Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, et al. Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol. 2007;178:3368\u201372. https:\/\/doi.org\/10.4049\/JIMMUNOL.178.6.3368.","journal-title":"J Immunol"},{"key":"2914_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2017.01187","volume":"8","author":"M Mart\u00edn-Vicente","year":"2017","unstructured":"Mart\u00edn-Vicente M, Medrano LM, Resino S, Garc\u00eda-Sastre A, Mart\u00ednez I. TRIM25 in the regulation of the antiviral innate immunity. Front Immunol. 2017;8: 1187. https:\/\/doi.org\/10.3389\/FIMMU.2017.01187.","journal-title":"Front Immunol"},{"key":"2914_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.VIRUSRES.2019.02.002","volume":"264","author":"NA Ilyushina","year":"2019","unstructured":"Ilyushina NA, Dickensheets H, Donnelly RP. A comparison of interferon gene expression induced by influenza A virus infection of human airway epithelial cells from two different donors. Virus Res. 2019;264:1\u20137. https:\/\/doi.org\/10.1016\/J.VIRUSRES.2019.02.002.","journal-title":"Virus Res"},{"key":"2914_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/J.1348-0421.2011.00396.X","volume":"55","author":"TTB Phung","year":"2011","unstructured":"Phung TTB, Sugamata R, Uno K, Aratani Y, Ozato K, Kawachi S, et al. Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A\/H1N1) infection in A549 bronchial epithelial cells. Microbiol Immunol. 2011;55:874. https:\/\/doi.org\/10.1111\/J.1348-0421.2011.00396.X.","journal-title":"Microbiol Immunol"},{"key":"2914_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/J.VIROL.2005.09.043","volume":"345","author":"V Veckman","year":"2006","unstructured":"Veckman V, \u00d6sterlund P, Fagerlund R, Mel\u00e9n K, Matikainen S, Julkunen I. TNF-\u03b1 and IFN-\u03b1 enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology. 2006;345:96\u2013104. https:\/\/doi.org\/10.1016\/J.VIROL.2005.09.043.","journal-title":"Virology"},{"key":"2914_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/V11020171","author":"R Meineke","year":"2019","unstructured":"Meineke R, Rimmelzwaan GF, Elbahesh H. Influenza virus infections and cellular kinases. Viruses. 2019. https:\/\/doi.org\/10.3390\/V11020171.","journal-title":"Viruses"},{"key":"2914_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/J.1440-1681.2011.05648.X","volume":"39","author":"SC Gupta","year":"2012","unstructured":"Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of the golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39:283. https:\/\/doi.org\/10.1111\/J.1440-1681.2011.05648.X.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2914_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES26226900","volume":"26","author":"D Mar\u00edn-Palma","year":"2021","unstructured":"Mar\u00edn-Palma D, Tabares-Guevara JH, Zapata-Cardona MI, Fl\u00f3rez-\u00e1lvarez L, Yepes LM, Rugeles MT, et al. Curcumin inhibits in vitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms. Molecules. 2021;26: 6900. https:\/\/doi.org\/10.3390\/MOLECULES26226900.","journal-title":"Molecules"},{"key":"2914_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0070225","volume":"8","author":"K Obata","year":"2013","unstructured":"Obata K, Kojima T, Masaki T, Okabayashi T, Yokota S, Hirakawa S, et al. Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells. PLoS One. 2013;8: e70225. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0070225.","journal-title":"PLoS One"},{"key":"2914_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/J.INTIMP.2017.11.009","volume":"54","author":"J Dai","year":"2018","unstructured":"Dai J, Gu L, Su Y, Wang Q, Zhao Y, Chen X, et al. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2\/4, p38\/JNK MAPK and NF-\u03baB pathways. Int Immunopharmacol. 2018;54:177\u201387. https:\/\/doi.org\/10.1016\/J.INTIMP.2017.11.009.","journal-title":"Int Immunopharmacol"},{"key":"2914_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/1440-1681.12848","volume":"45","author":"S Han","year":"2018","unstructured":"Han S, Xu J, Guo X, Huang M. Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production. Clin Exp Pharmacol Physiol. 2018;45:84\u201393. https:\/\/doi.org\/10.1111\/1440-1681.12848.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2914_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/S12272-020-01230-5","volume":"43","author":"Y Lai","year":"2020","unstructured":"Lai Y, Yan Y, Liao S, Li Y, Ye Y, Liu N, et al. 3D-quantitative structure\u2013activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase. Arch Pharm Res. 2020;43:489\u2013502. https:\/\/doi.org\/10.1007\/S12272-020-01230-5.","journal-title":"Arch Pharm Res"},{"key":"2914_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/IRV.12459","volume":"11","author":"Y Xu","year":"2017","unstructured":"Xu Y, Liu L. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-\u03baB signaling pathway. Influenza Other Respi Viruses. 2017;11:457\u201363. https:\/\/doi.org\/10.1111\/IRV.12459.","journal-title":"Influenza Other Respi Viruses"},{"key":"2914_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES191220091","volume":"19","author":"KI Priyadarsini","year":"2014","unstructured":"Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19: 20091. https:\/\/doi.org\/10.3390\/MOLECULES191220091.","journal-title":"Molecules"},{"key":"2914_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/LIFE13010207","volume":"13","author":"J G\u00f3rnicka","year":"2023","unstructured":"G\u00f3rnicka J, Mika M, Wr\u00f3blewska O, Siudem P, Paradowska K. Methods to improve the solubility of curcumin from turmeric. Life (Basel). 2023;13: 207. https:\/\/doi.org\/10.3390\/LIFE13010207.","journal-title":"Life (Basel)"},{"key":"2914_CR22","doi-asserted-by":"publisher","first-page":"16058","DOI":"10.3390\/MOLECULES191016058","volume":"19","author":"SW Leong","year":"2014","unstructured":"Leong SW, Mohd Faudzi SM, Abas F, Mohd Aluwi MFF, Rullah K, Wai LK, et al. Synthesis and Sar Study of Diarylpentanoid Analogues as New Anti-Inflammatory Agents. Mol. 2014;19:16058\u201381. https:\/\/doi.org\/10.3390\/MOLECULES191016058.","journal-title":"Mol"},{"key":"2914_CR23","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1016\/J.BMCL.2015.05.056","volume":"25","author":"SW Leong","year":"2015","unstructured":"Leong SW, Mohd Faudzi SM, Abas F, Mohd Aluwi MFF, Rullah K, Lam KW, et al. Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives. Bioorg Med Chem Lett. 2015;25:3330\u20137. https:\/\/doi.org\/10.1016\/J.BMCL.2015.05.056.","journal-title":"Bioorg Med Chem Lett"},{"key":"2914_CR24","first-page":"1","volume":"2","author":"F Azmi","year":"2016","unstructured":"Azmi F, Leong SW, Abas F, Ming OH, Perimal EK, Akira A, et al. Antinociceptive effect of 2-benzoyl-6-(3,4-dihydroxybenzylidene)cyclohexen-1-ol on nociception induced models in mice. J Pharmacol Toxicol Investig. 2016;2:1\u20139.","journal-title":"J Pharmacol Toxicol Investig"},{"key":"2914_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES23092099","volume":"23","author":"N Kamarudin","year":"2018","unstructured":"Kamarudin N, Hisamuddin N, Ong HM, Ahmad Azmi AF, Leong SW, Abas F, et al. Analgesic effect of 5-(3,4-dihydroxyphenyl)-3-hydroxy-1-(2-hydroxyphenyl)penta-2,4-dien-1-one in experimental animal models of nociception. Molecules. 2018;23: 2099. https:\/\/doi.org\/10.3390\/MOLECULES23092099.","journal-title":"Molecules"},{"key":"2914_CR26","first-page":"10","volume":"15","author":"KY Liew","year":"2019","unstructured":"Liew KY, Rosly NA, Abas F, Leong SW, Israf DA, Tham CL. Effect of diarylpentanoid analogues on lipopolysaccharide-induced interleukin-6 and interleukin-8 gene expression in airway inflammation. Malaysian J Med Heal Sci. 2019;15:10\u20137.","journal-title":"Malaysian J Med Heal Sci"},{"key":"2914_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-024-00542-x","author":"KY Liew","year":"2024","unstructured":"Liew KY, Chee HY, Abas F, Leong SW, Harith HH, Israf DA, et al. A synthetic curcumin-like diarylpentanoid analog inhibits rhinovirus infection in H1 hela cells via multiple antiviral mechanisms. DARU J Pharm Sci. 2024. https:\/\/doi.org\/10.1007\/s40199-024-00542-x.","journal-title":"DARU J Pharm Sci"},{"key":"2914_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/OXFORDJOURNALS.AJE.A118408\/2\/27-3-493.PDF.GIF","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27:493\u20137. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.AJE.A118408\/2\/27-3-493.PDF.GIF.","journal-title":"Am J Epidemiol"},{"key":"2914_CR29","doi-asserted-by":"publisher","first-page":"e2830","DOI":"10.21769\/BIOPROTOC.2830","volume":"8","author":"C Aoki-Utsubo","year":"2018","unstructured":"Aoki-Utsubo C, Chen M, Hotta H. Time-of-addition and Temperature-shift Assays to Determine Particular Step(s) in the Viral Life Cycle that is Blocked by Antiviral Substance(s). Bio Protoc. 2018;8:e2830. https:\/\/doi.org\/10.21769\/BIOPROTOC.2830.","journal-title":"Bio Protoc."},{"issue":"11","key":"2914_CR30","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1128\/AAC.00721-10","volume":"54","author":"B Mercorelli","year":"2010","unstructured":"Mercorelli B, Oreste P, Sinigalia E, Muratore G, Lembo D, Pal\u00f9 G, et al. Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus. Antimicrob Agents Chemother. 2010;54(11):4561. https:\/\/doi.org\/10.1128\/AAC.00721-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"2914_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/MICROBIOLRES13040060","volume":"13","author":"M Hessling","year":"2022","unstructured":"Hessling M, Fehler N, Gierke AM, Sicks B, Vatter P. Heat Inactivation of Influenza Viruses&mdash;Analysis of Published Data and Estimations for Required Decimal Reduction Times for Different Temperatures and Media. Microbiol Res. 2022;13:853\u201371. https:\/\/doi.org\/10.3390\/MICROBIOLRES13040060.","journal-title":"Microbiol Res"},{"key":"2914_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/JIR.2014.0227","volume":"35","author":"S Davidson","year":"2015","unstructured":"Davidson S, Maini MK, Wack A. Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interf Cytokine Res. 2015;35:252. https:\/\/doi.org\/10.1089\/JIR.2014.0227.","journal-title":"J Interf Cytokine Res"},{"key":"2914_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12985-022-01764-8","volume":"19","author":"Y Hu","year":"2022","unstructured":"Hu Y, Pan Q, Zhou K, Ling Y, Wang H, Li Y. RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling. Virol J. 2022;19:1\u201314. https:\/\/doi.org\/10.1186\/S12985-022-01764-8.","journal-title":"Virol J"},{"key":"2914_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/V12040377","author":"W Wu","year":"2020","unstructured":"Wu W, Zhang W, Tian L, Brown BR, Walters MS, Metcalf JP. IRF7 is required for the second phase interferon induction during influenza virus infection in human lung epithelia. Viruses. 2020. https:\/\/doi.org\/10.3390\/V12040377.","journal-title":"Viruses"},{"key":"2914_CR35","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/J.FOODCHEM.2009.09.011","volume":"119","author":"DY Chen","year":"2010","unstructured":"Chen DY, Shien JH, Tiley L, Chiou SS, Wang SY, Chang TJ, et al. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem. 2010;119:1346\u201351. https:\/\/doi.org\/10.1016\/J.FOODCHEM.2009.09.011.","journal-title":"Food Chem"},{"key":"2914_CR36","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1111\/FEBS.12503","volume":"280","author":"JL Ou","year":"2013","unstructured":"Ou JL, Mizushina Y, Wang SY, Chuang DY, Nadar M, Hsu WL. Structure\u2013activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J. 2013;280:5829\u201340. https:\/\/doi.org\/10.1111\/FEBS.12503.","journal-title":"FEBS J"},{"key":"2914_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/PH12040147","volume":"12","author":"SCJH Chua","year":"2019","unstructured":"Chua SCJH, Tan HQ, Engelberg D, Lim LHK. Alternative experimental models for studying influenza proteins, host-virus interactions and anti-influenza drugs. Pharmaceuticals. 2019;12: 147. https:\/\/doi.org\/10.3390\/PH12040147.","journal-title":"Pharmaceuticals"},{"key":"2914_CR38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/J.TJOG.2012.07.009","volume":"51","author":"CC Chang","year":"2012","unstructured":"Chang CC, Fu CF, Yang WT, Chen TY, Hsu YC. The cellular uptake and cytotoxic effect of curcuminoids on breast cancer cells. Taiwan J Obstet Gynecol. 2012;51:368\u201374. https:\/\/doi.org\/10.1016\/J.TJOG.2012.07.009.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2914_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0062482","volume":"8","author":"TY Chen","year":"2013","unstructured":"Chen TY, Chen DY, Wen HW, Ou JL, Chiou SS, Chen JM, et al. Inhibition of enveloped viruses infectivity by curcumin. PLoS One. 2013;8: e62482. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0062482.","journal-title":"PLoS One"},{"key":"2914_CR40","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2174\/1568026617666170224122508","volume":"17","author":"Y Hu","year":"2017","unstructured":"Hu Y, Sneyd H, Dekant R, Wang J. Influenza A virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target. Curr Top Med Chem. 2017;17:2271. https:\/\/doi.org\/10.2174\/1568026617666170224122508.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"2914_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/v12040377","volume":"12","author":"W Wu","year":"2020","unstructured":"Wu W, Zhang W, Tian L, Brown BR, Walters MS, Metcalf JP. IRF7 is required for the second phase interferon induction during influenza virus infection in human lung epithelia. Viruses. 2020;12(4):377. https:\/\/doi.org\/10.3390\/v12040377.","journal-title":"Viruses"},{"key":"2914_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLIM.2020.108652","volume":"223","author":"VA Ryabkova","year":"2020","unstructured":"Ryabkova VA, Churilov LP, Shoenfeld Y. Influenza infection, SARS, MERS and COVID-19: Cytokine storm \u2013 The common denominator and the lessons to be learned. Clin Immunol. 2020;223: 108652. https:\/\/doi.org\/10.1016\/J.CLIM.2020.108652.","journal-title":"Clin Immunol"},{"issue":"1","key":"2914_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","volume":"46","author":"S Prasad","year":"2014","unstructured":"Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014;46(1):2\u201318. https:\/\/doi.org\/10.4143\/crt.2014.46.1.2.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"2914_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1124\/jpet.117.245068","volume":"365","author":"EG El Nebrisi","year":"2018","unstructured":"El Nebrisi EG, Bagdas D, Toma W, Al Samri H, Brodzik A, Alkhlaif Y, Yang KH, Howarth FC, Damaj IM, Oz M. Curcumin acts as a positive allosteric modulator of \u03b17-nicotinic acetylcholine receptors and reverses nociception in mouse models of inflammatory pain. J Pharmacol Exp Ther. 2018;365(1):190\u2013200. https:\/\/doi.org\/10.1124\/jpet.117.245068.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2914_CR45","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1089\/vim.2013.0095","volume":"13","author":"D Yao","year":"2022","unstructured":"Yao D, Bao L, Li F, Liu B, Wu X, Hu Z, Xu J, Wang W, Zhang X. H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1\/3 activation are associated with pulmonary immunopathological damage. Virulence. 2022;13(1):1558\u201372. https:\/\/doi.org\/10.1089\/vim.2013.0095.","journal-title":"Virulence"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02914-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:11:40Z","timestamp":1761847900000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02914-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2914"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02914-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}